Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swift Biosciences announced on Wednesday the recent completion of a $3 million Series A financing round led by venture firm DFJ Mercury.

Also participating in the round were several unnamed Michigan-based individual investors who provided seed funding to Swift when it launched in January. The company also said that Daniel Watkins, a managing director at DFJ Mercury, is joining Swift's board.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.